- Contractors
- Versatope Therapeutics Inc
Versatope Therapeutics Inc
Federal contractor · Research and Development in Biotechnology (except Nanobiotechnology)
Versatope Therapeutics has 1 federal contract of $100,000 or more active since October 2023, with $16.8M obligated, from 1 agency. None is running now.
- Contracts
- 1 since FY2024$16,754,610 obligated, contracts of $100,000 or more
- Running now
- None
- Biggest customer
- National Institutes of Health$16.8M on 1 contract
- Main industry
- Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714
- UEI
- VSMPM3EGYYA6Unique entity ID in SAM.gov
- Source
- USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC
Running contracts
No contract of $100,000 or more is running now.
Who they work for
| Agency | Amount | Share |
|---|---|---|
| National Institutes of Health1 contract | $16,754,610 |
What they sell
| Industry | Amount | Share |
|---|---|---|
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 · 1 contract | $16,754,610 |
Where the work is
| Place of work | Amount | Share |
|---|---|---|
| Massachusetts1 contract | $16,754,610 |
Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at National Institutes of Health: see the list.
Get new notices like Versatope Therapeutics's work
New contract opportunities under NAICS 541714, research and development in biotechnology (except nanobiotechnology), the morning they appear. Free while in beta.
Free. We use your email only for these alerts and never share it. Privacy